These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 8164353)

  • 1. [Pharmacological action of 9alpha-fluorohydrocortisone as a mineralocorticoid].
    Sekihara H
    Nihon Rinsho; 1994 Mar; 52(3):583-6. PubMed ID: 8164353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mineralocorticoid and glucocorticoid receptors and their differential effects on memory performance in people with Addison's disease.
    Tytherleigh MY; Vedhara K; Lightman SL
    Psychoneuroendocrinology; 2004 Jul; 29(6):712-23. PubMed ID: 15110920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The selective mineralocorticoid receptor modulator AZD9977 reveals differences in mineralocorticoid effects of aldosterone and fludrocortisone.
    Bamberg K; William-Olsson L; Johansson U; Jansson-Löfmark R; Hartleib-Geschwindner J
    J Renin Angiotensin Aldosterone Syst; 2019; 20(1):1470320319827449. PubMed ID: 30813831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial natriuretic peptide and plasma renin levels in assessment of mineralocorticoid replacement in Addison's disease.
    Cohen N; Gilbert R; Wirth A; Casley D; Jerums G
    J Clin Endocrinol Metab; 1996 Apr; 81(4):1411-5. PubMed ID: 8636343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mineralocorticoid substitution and monitoring in primary adrenal insufficiency.
    Quinkler M; Oelkers W; Remde H; Allolio B
    Best Pract Res Clin Endocrinol Metab; 2015 Jan; 29(1):17-24. PubMed ID: 25617169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synthetic mineralocorticoid].
    Miyamori I
    Nihon Rinsho; 2008 Jan; 66(1):125-9. PubMed ID: 18193551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of atrial natriuretic peptide (ANP) during mineralocorticoid escape in normal man.
    Wambach G; Götz S; Suckau G; Kaufmann W
    Klin Wochenschr; 1986; 64 Suppl 6():53-7. PubMed ID: 2948064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A mineralocorticoid effective by oral administration: 9-alpha-fluorohydrocortisone (Astonin H)].
    Maximilian VV; Oancea R; Lazăr V
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1977; 29(5):469-72. PubMed ID: 24883
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence that high dose cortisol-induced Na+ retention in man is not mediated by the mineralocorticoid receptor.
    Whitworth JA; Kelly JJ
    J Endocrinol Invest; 1995; 18(7):586-91. PubMed ID: 9221279
    [No Abstract]   [Full Text] [Related]  

  • 10. The action of fludrocortisone and aldosterone on sodium potassium metabolism in Addison's disease.
    MUNRO DS
    Clin Sci; 1958; 17(2):205-16. PubMed ID: 13537340
    [No Abstract]   [Full Text] [Related]  

  • 11. Glucocorticoids with or without fludrocortisone in septic shock: a narrative review from a biochemical and molecular perspective.
    Nethathe GD; Lipman J; Anderson R; Fuller PJ; Feldman C
    Br J Anaesth; 2024 Jan; 132(1):53-65. PubMed ID: 38030548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of administered mineralocorticoids or ACTH in pregnant women. Attenuation of kaliuretic influence of mineralocorticoids during pregnancy.
    Ehrlich EN; Lindheimer MD
    J Clin Invest; 1972 Jun; 51(6):1301-9. PubMed ID: 4336938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exogenous mineralocorticoid hormone improves predialysis hyperkalemia in anephric man.
    Whalen JE; Cohen LH
    Proc Clin Dial Transplant Forum; 1978 Nov 18-20; 8():1-4. PubMed ID: 756027
    [No Abstract]   [Full Text] [Related]  

  • 14. Severe symptomatic hyperkalemia in an adrenalectomized woman due to enhanced mineralocorticoid requirement.
    Daughaday WH; Rendleman D
    Ann Intern Med; 1967 Jun; 66(6):1197-203. PubMed ID: 6027948
    [No Abstract]   [Full Text] [Related]  

  • 15. Case report: severe neonatal hyperkalemia due to pseudohypoaldosteronism type 1.
    Schweiger B; Moriarty MW; Cadnapaphornchai MA
    Curr Opin Pediatr; 2009 Apr; 21(2):269-71. PubMed ID: 19657313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone resistance in kidney transplantation is in part induced by a down-regulation of mineralocorticoid receptor expression.
    Heering PJ; Kurschat C; Vo DT; Klein-Vehne N; Fehsel K; Ivens K
    Clin Transplant; 2004 Apr; 18(2):186-92. PubMed ID: 15016134
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid resistance.
    Zennaro MC
    Steroids; 1996 Apr; 61(4):189-92. PubMed ID: 8732998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineralocorticoid replacement in Addison's disease.
    Thompson DG; Mason AS; Goodwin FJ
    Clin Endocrinol (Oxf); 1979 May; 10(5):499-506. PubMed ID: 476980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among urinary kallikrein, mineralocorticoids and human hypertensive disease.
    Margolius HS; Horwitz D; Pisano JJ; Keiser HR
    Fed Proc; 1976 Feb; 35(2):203-6. PubMed ID: 1248655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High plasma levels of endothelin-1 in untreated Addison's disease.
    Letizia C; Centanni M; Scuro L; Canettieri G; Cerci S; De Ciocchis A; D'Ambrosio C; Scavo D
    Eur J Endocrinol; 1996 Dec; 135(6):696-9. PubMed ID: 9025715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.